{
    "2018-07-05": [
        [
            {
                "time": "2018-07-03",
                "original_text": "Some Recent Pharmaceutical Mergers and Acquisitions",
                "features": {
                    "keywords": [
                        "Mergers",
                        "Acquisitions",
                        "Pharmaceutical"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "Fed minutes warn of rising trade risks",
                "features": {
                    "keywords": [
                        "Fed",
                        "minutes",
                        "trade",
                        "risks"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "Everett-based Fortive Corp. is eager to deploy its $4B M&A war chest",
                "features": {
                    "keywords": [
                        "Fortive",
                        "Corp.",
                        "M&A",
                        "war chest"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "Kiplinger Dividend 15: CVS Interrupts Its String of Hikes",
                "features": {
                    "keywords": [
                        "Kiplinger",
                        "Dividend",
                        "CVS",
                        "Interrupts",
                        "Hikes"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "Here's Why AbbVie Stock is Good for Your Portfolio's Health",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Stock",
                        "Portfolio",
                        "Health"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "JNK, HCRF: Big ETF Outflows",
                "features": {
                    "keywords": [
                        "JNK",
                        "HCRF",
                        "ETF",
                        "Outflows"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "Pfizer's Stock Ready for a 10% Rebound",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Stock",
                        "Rebound"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "An Update on JNJ’s Neuroscience Business after Q1 2018",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Neuroscience",
                        "Q1",
                        "2018"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "Merck & Co.: Wall Street Analysts Are Mostly Positive in July",
                "features": {
                    "keywords": [
                        "Merck",
                        "&",
                        "Co.",
                        "Wall",
                        "Street",
                        "Analysts",
                        "Positive",
                        "July"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "JNJ’s Infectious Diseases Segment Witnessed ~11% YoY Growth",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Infectious",
                        "Diseases",
                        "Segment",
                        "Growth"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "An Update on Johnson & Johnson’s Immunology Business",
                "features": {
                    "keywords": [
                        "Johnson",
                        "&",
                        "Johnson",
                        "Immunology",
                        "Business"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}